Funded Projects

Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.

Reset
Project # Project Title Research Focus Area Research Program Administering IC Institution(s) Investigator(s) Location(s) Year Awarded
1R21DA062182-01
The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System Cross-Cutting Research NIDA RAND CORPORATION KALMIN, MARIAH Santa Monica, CA 2024
NOFO Title: Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
NOFO Number: RFA-DA-24-037
3OT2OD030208-01S3
Helping to End Addiction Long-term (HEAL) Data Platform Cross-Cutting Research OD UNIVERSITY OF CHICAGO GROSSMAN, ROBERT L Chicago, IL 2024
NOFO Title: HEAL RfN FY2020
NOFO Number: OTA-20-007
3OT2OD031940-01S3
A Strategy for Heal Federated Data Ecosystem Cross-Cutting Research OD UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL GOSWAMI, SUPARNA Chapel Hill, NC 2024
NOFO Title: HEAL data coordination and research platform (Data Corp)
NOFO Number: OTA-21-002
1R01DA060183-01A1
Localize Opioid Use Disorder (LOUD) response to increase medication access Cross-Cutting Research NIDA UNIVERSITY OF PITTSBURGH JOUDREY, PAUL J (contact); KOLAK, MARYNIA Pittsburgh, PA 2024
NOFO Title: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
NOFO Number: PA-20-185
1R21DA059665-01A1
Characterizing Information Needs and Peer Engagement Regarding Medication for Opioid Use Disorder on Social Media Cross-Cutting Research NIDA DARTMOUTH COLLEGE PREUM, SARAH MASUD Hanover, NH 2024
NOFO Title: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
NOFO Number: PA-20-195
3R44DA049685-03S1
Noninvasive Brain Stimulation for Treating Addiction (Supplement) Cross-Cutting Research Small Business Programs NIDA HIGHLAND INSTRUMENTS, INC. WAGNER, TIMOTHY ANDREW (contact); DIPIETRO, LAURA Sharon, MA 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
3R01DA057605-01S3
Enhancing opioid surveillance in RADOR-KY using social media Cross-Cutting Research Leveraging Existing and Real-Time Opioid and Pain Management Data NIDA UNIVERSITY OF KENTUCKY SLAVOVA, SVETLA STEFANOVA (contact); TALBERT, JEFFERY C Lexington, KY 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
3R01DA057668-01S1
Enhancing Precision in Overdose Mortality Prediction through Data Linkage: A Heterogeneous Capture-Recapture Approach to Estimating Opioid Use Disorder Prevalence in Ohio Cross-Cutting Research Leveraging Existing and Real-Time Opioid and Pain Management Data NIDA OHIO STATE UNIVERSITY FERNANDEZ, SOLEDAD A (contact); FAREED, NALEEF Columbus, OH 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
1R43DA058603-01A1
Developing a novel epigenetic regulator as a treatment for opioid use disorder Cross-Cutting Research Small Business Programs NIDA EPIVARIO, LLC KIM, THOMAS Philadelphia, PA 2024
NOFO Title: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-22-176
1R43DA060033-01A1
Xylazine and opioid overdose mitigation therapy using decoy receptor biomimetic nanoparticles, NarcoBond platform Cross-Cutting Research Small Business Programs NIDA CIBOTS, INC. ESMAELI-AZAD, BABAK San Diego, CA 2024
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-23-230
1R43DA059315-01A1
Extending duration of an injectable long-acting local anesthetic formulation using novel salts Cross-Cutting Research Small Business Programs NIDA REBEL MEDICINE, INC. DAVIS, BRETT Salt Lake City, UT 2024
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-23-230
1R44DA061722-01
NX90: A Treatment for Overdose Caused by High Potency Opioids Cross-Cutting Research Small Business Programs NIDA SERODOPA THERAPEUTICS, INC. VORONKOV, MICHAEL V Gainesville, FL 2024
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-23-230
1R43DA060717-01
Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients Cross-Cutting Research Small Business Programs NIDA ADDINEX TECHNOLOGIES, INC. ROSLYAKOV, STANISLAV New York, NY 2024
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
NOFO Number: PA-23-231
1R21DA061660-01
Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach Cross-Cutting Research NIDA NEW YORK UNIVERSITY SCHOOL OF MEDICINE KRAWCZYK, NOA (contact); JORDAN, ASHLY ELIZABETH New York, NY 2024
NOFO Title: Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
NOFO Number: PAR-22-027
1R43DA061400-01
Remote and Non-Invasive Opioid Use Screening to Lower Barriers to Substance Use Disorder Diagnosis and Treatment Cross-Cutting Research Small Business Programs NIDA TENVOS, INC. SEIILOVA-OLSON, RIMA West Sacramento, CA 2024
NOFO Title: Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional)
NOFO Number: RFA-DA-24-018
4R33DA059169-02
Leveraging Data to Action: Accelerating Emergency Department OUD Care by Improving Data Access and Infrastructure Cross-Cutting Research HEAL Data2Action (HD2A) NIDA YALE UNIVERSITY VENKATESH, ARJUN KRISHNA (contact); HAWK, KATHRYN; TAYLOR, RICHARD ANDREW New Haven, CT 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)
NOFO Number: RFA-DA-23-057
4R33DA059163-02
Supporting data-driven decision-making to support substance use service expansion policies and to prevent overdoses Cross-Cutting Research HEAL Data2Action (HD2A) NIDA CHESTNUT HEALTH SYSTEMS, INC. CRUDEN, GRACELYN Eugene, OR 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)
NOFO Number: RFA-DA-23-057
4R44DA058467-02
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder Cross-Cutting Research Small Business Programs NIDA VIVREON BIOSCIENCES, LLC GREENBERG, MILTON L San Diego, CA 2024
NOFO Title: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
NOFO Number: RFA-DA-23-021
1R44DA060643-01
Developing a wearable medical device to detect opioid overdose Cross-Cutting Research Small Business Programs NIDA RESILIENT LIFESCIENCE, INC. HOLDEN, BRADFORD A Pittsburgh, PA 2024
NOFO Title: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
NOFO Number: RFA-DA-23-021
4R33DA057667-02
CADENCE - Continuous And Data-drivEN CarE Cross-Cutting Research HEAL Data2Action (HD2A) NIDA UNIVERSITY OF SOUTH FLORIDA MARSHALL, JENNIFER (contact); WRIGHT, TANNER Tampa, FL 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051
4R33DA057610-02
Improving pain management and opioid safety through a systemwide, data driven evaluation of the CDC opioid prescribing guideline best practices and the use of Clinical Decision Support Cross-Cutting Research HEAL Data2Action (HD2A) NIDA UNIVERSITY OF COLORADO DENVER HOPPE, JASON Aurora, CO 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051
2R42DA056254-02
Development of negative allosteric modulators of the mu-opioid receptor for the management of opioid use disorder Cross-Cutting Research Small Business Programs NIDA ELEVEN THERAPEUTICS CORP TRAYNOR, JOHN R Encinitas, CA 2024
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
NOFO Number: PA-23-232
4R44DA053845-02
Fast-track: Scalable digital delivery of evidence-based training for addiction professionals to maximize treatment admission and retention rates of opioid use disorder in affected families Cross-Cutting Research Small Business Programs NIDA WE THE VILLAGE, INC. MACKY, JANE Brooklyn, NY 2024
NOFO Title: HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)
NOFO Number: RFA-DA-19-019
4R33DA057660-02
Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS) Cross-Cutting Research HEAL Data2Action (HD2A) NIDA INDIANA UNIVERSITY INDIANAPOLIS AALSMA, MATTHEW (contact); RAY, BRADLEY; REDA, KHAIRI Indianapolis, IN 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051
4R33DA057600-02
Using data to drive action to reduce opioid overdoses in Seattle, WA Cross-Cutting Research HEAL Data2Action (HD2A) NIDA UNIVERSITY OF WASHINGTON BANTA-GREEN, CALEB (contact); HOOD, JULIA ELIZABETH Seattle, WA 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051